Login / Signup

Research progress on small-molecule inhibitors of protein arginine methyltransferase 5 (PRMT5) for treating cancer.

Chaohua GuoLintao WuXumei ZhengLin ZhaoXiaojia HouZhijun WangChun Han
Published in: Current topics in medicinal chemistry (2023)
These inhibitors are beneficial to the treatment of tumors. Some drugs are being used in clinical trials. PRMT5 inhibitors have broad application prospects in tumor therapy.
Keyphrases
  • small molecule
  • clinical trial
  • protein protein
  • nitric oxide
  • papillary thyroid
  • amino acid
  • stem cells
  • squamous cell carcinoma
  • binding protein
  • bone marrow
  • open label
  • study protocol
  • phase ii
  • drug induced